The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans
The company has reported total income of Rs. 815.11 crores during the period ended March 31, 2023
These announcements are in line with Croda Pharma’s strategy to “Empower Biologics Delivery” and follows news on investments, earlier this year, to expand Croda Pharma’s global manufacturing capabilities to enable the next generation vaccines and therapeutic drugs.
The USFDA had classified Strides Puducherry facility as OAI in May 2019 followed by issuing a warning letter to this site in July 2019.
Testing supporting allergy diagnosis now accessible to more people in more communities
This latest audit re-emphasizes Hikal's commitment towards maintaining the best in class quality, compliance and regulatory standards across our manufacturing sites
The Indian pharmaceutical industry includes a network of 3,000 drug companies and 10,500 manufacturing units. It is projected to reach a value of US$ 130 billion by 2030
Cautions against fragmented & siloed efforts in addressing the challenges faced by the world and underlined the need for collaborative efforts to ensure global health security
Dr. Reddy's Laboratories has been issued a Form 483 with four observations
Milan is also an important hub for the distribution of pharmaceuticals to the rest of Europe
Subscribe To Our Newsletter & Stay Updated
